medigraphic.com
ISSN 3061-8142 (Electronic)
ISSN 0484-7903 (Print)

2015, Number 3

<< Back Next >>

Rev Mex Anest 2015; 38 (3)

Use of beta-blockers in the perioperative period

Carrillo-Esper R, Nava-López JA, Lozano-Marrujo I, Zepeda MAD, Carrillo-Córdoba DM, Carrillo CCA

Language: Spanish
References: 19
Page: 178-186
PDF size: 228.71 Kb.


ABSTRACT

Cardiac events are common complications of surgery, occurring in 1 to 5% of unselected patients undergoing noncardiac surgery. Until recently, attempts to reduce the incidence of these complications depend on perioperative risk assessments followed by clinical recommendations. Several recent randomized trials have examined the effects of perioperative beta-blockers in patients with outcomes including perioperative ischemia, myocardial infarction and mortality. Despite the heterogeneity of the trials, the growing literature suggests a benefit of beta-blockers in preventing perioperative cardiac morbidity. It is essential that the decision to use beta-blockers is made on a case by case based on risk stratification as part of the criteria. The objective of this work is to evaluate the current medical literature on the use of perioperative beta-blockade for reducing cardiac events.


REFERENCES

  1. Lefkowitz RJ, Hoffman BB, Taylor P. Neurotransmisión sistemas nervioso autónomo y motor somático. En: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: Las bases farmacológicas de la terapéutica. 11a ed. México: McGraw-Hill; 2006. p. 113-147.

  2. Tamargo-Menéndez J, Delpón-Mosquera E. Farmacología de los bloqueantes de los receptores beta-adrenérgicos [Internet]. Editores CardioTeca; 2013. [actualizado 22 agosto 2013, citado 09 junio 2014]. Disponible en: www.cardioteca.com/centro-de-recursos-clinicos-bisoprolol/644-farmacologia-clinica-de-los-betabloqueantes.html

  3. Poldermans D, Boersma E, DeHert E, Eeckchout E, Fowles G, Gorenek B, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardic surgery. European Heart Journal [Internet]. 2009 [citado 14 junio 2014];30:2769-2812. Available in: http://eurheartj.oxfordjournals.org/content/30/22/2769.full.pdf+html?etoc

  4. Fleischmann KE, Beckman JA, Calkins h, Fleisher LA, Freeman WK, Froehlich JB, et al. ACCF/AHA focused update on perioperative beta blockade. JACC [internet]. 2009 [citado 14 junio 2014];54. Available in: http://content.onlinejacc.org/cgi/content/full/j.jacc.2009.07.004v1

  5. Shamsuddin A, Barash PG. Perioperative use of beta-blockers: past, present and future. Int Anesthesiol Clin. 2002;40:133-157.

  6. Fontes ML, Varon J. Perioperative hypertension crisis: newer concepts. Int Anesthesiol Clin. 2012;50:40-58.

  7. Varon J, Marik PE. Perioperative hypertension management. Vasc Health Risk Manag. 2008;4:615-627.

  8. Yu SKH, Tait G, Karkouti K, Wijeysundera D, McCluskey S, Beattie WS. The safety of perioperative esmolol: a systematic review and meta-analysis of randomized controlled trials. Anesthesia & Analgesia. 2011;112:267-281.

  9. Zangrillo A, Turi S, Crescenzi G, Oriani A, Distaso F, Monaco F, et al. Esmolol reduces perioperative ischemia in cardiac surgery: a meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth. 2009;23:625-632.

  10. Celebi N, Cozmeci EA, Canbay O. Intraoperative esmolol infusion reduces postoperative analgesic consumption an anaesthetic use during septorhinoplasty: a randomized trial Science Direct [Internet]. 2014 [actualizado 02 febrero 2014, citado 16 junio 2014]. Available in: www.sciencedirect.com/science/article/pii/S01040014000037.

  11. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blakensteijn JD, et al. The effect on bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echoicardiography Study Group. N Engl J Med. 1999;341:1789-1794.

  12. Harte B, Jaffer AK. Periopertaive beta-blockers in noncardiac surgery: evolution of the evidence. CCJM. 2014;75:513-519.

  13. Brady AR, Gibbs Js, Greenhalgh RM, Powell JT, Sydes MR. Perioperative betablockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 2005; 41:602-609.

  14. Yang H, Raymer K, Butler R, Parlow J, Roberrts R. The effect of perioperative beta -blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 2006; 152:938-990.

  15. Juul AB. Wetterslev J, Gludd C, Kofoed-Enevoldsen A, Jesen G, Callensen T, Norgaard P, et al. Effect of perioperative beta blockade in patients with diabetes ungergoing major non-cardiac surgery: randomized placebo controlled, blinded multricentre trial. BMJ 2006; 332: 1482.

  16. Deveraux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, et al. Effects of extend-realease metoprolol succinato in patients undergoing non-cardiac surgery ( POISE trial): a randomized controlled trial. Lancet 2008;371:1839-1847.

  17. Wijeysundera DN, Duncan D, Nkonde-Price C, Virani SS, Washam JB, Fleischmann KE, et al. Perioperative Beta Blockade in Noncardiac Surgery: A Systematic Review for the 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. JACC 2014;64(22):2406–2425

  18. Penachi-Bosco FA, Cerqueira-Braz JR. Beta-blocker in anesthesiology: clinical and pharmacalogical aspects. Rev Bras Anestesiol. 2001;51:431-447.

  19. Horn JR, Hansten PD. The dangerous of beta-blockers and epinephrine. Pharmacy Times. 2005;09:31.




2020     |     www.medigraphic.com